redhill biopharma stock forecast

RedHill Biopharma has an average price target upside of 99827 Freeline Therapeutics Holdings has an average price target upside of 97800 Aslan Pharmaceuticals has an average price target upside of 95263. This suggests a possible upside of 7582 from the stocks current price.

Cwafslgfzarlum

Over the last 52-week period shares are down 4661.

. Given that these returns are generally positive. Shares of Rimini Street were trading at 453 as of February 28. Todays Range 130 139.

The increasing awareness of the disease developing therapies and improved diagnostic methods will drive the current Bronchiectasis therapeutic landscape. Over the last 52-week period shares are up 21415. Given that these returns are generally negative long-term.

View analysts price targets for RedHill Biopharma or view top-rated stocks among Wall Street analysts. On average they expect RedHill Biopharmas stock price to reach 1725 in the next twelve months. Petros Pharmaceuticals Stock Forecast Price News 136 004 303 As of 0322022 1200 AM ET Add.

Their forecasts range from 1000 to 2200. Several key pharmaceutical companies including Insmed Inc Novartis RedHill Biopharma Limited and others are developing novel products to improve the Bronchiectasis treatment outlook. Shares of SilverBow Resources were trading at 2572 as of February 28.

Rdhl Stock Price And Chart Nasdaq Rdhl Tradingview